A case of recurrent chronic eosinophilic pneumonia after switching from benralizumab to dupilumab
Dupilumab inhibits interleukin-4Rα and suppresses type 2 inflammation. Careful administration of dupilumab is required because it increases the blood eosinophil count secondary to a decrease in local eosinophil counts, sometimes resulting in eosinophilic complications. We herein report a case of rec...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2024-01-01
|
| Collection: | Respiratory Medicine Case Reports |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2213007123001636 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|